Europe Vascular Access Devices Market

Europe Vascular Access Devices Market Size

The vascular access devices market size in Europe was valued at USD 1.24 billion in 202. The European market is further estimated to grow at a CAGR of 7.14% CAGR from 2024 to 2032 and be worth USD 2.31 billion by 2032 from USD 1.33 billion in 2024.

MARKET DRIVERS

The major factors that are boosting the growth of the Europe vascular access devices market are the increasing incidence of chronic disease, changes in lifestyles of people, the increasing geriatric population, the high demand for these devices among people affected with chronic conditions, and the emergence of novel and innovative therapeutic methods due to technological developments. The rise in the number of chemotherapy treatments and applications of vascular access devices among pediatric patients are also boosting the growth of the vascular access devices market in Europe. Additionally, growing incidences of chronic diseases among many individuals, continuously increasing demand for active vascular access devices, the increasing prevalence of the geriatric population and the emergence of technically vascular advanced devices are foreseen to provide lucrative growth to the Europe vascular access devices market. 

MARKET RESTRAINTS

The factors that are resisting the growth of the Europe vascular access devices market are the risk of reduction of blood flow and thrombosis associated with vascular access devices and stringent guidelines of the FDA approval process to control vascular infections.

REGIONAL ANALYSIS

The European market is expected to account for the second-largest share of the market. Market growth in this region is primarily driven by factors such as the high prevalence of cardiovascular diseases, the increasing number of research studies and clinical trials for vascular access devices, and the increase in chemotherapy procedures. The UK market is dominating Europe and is anticipated to contribute the most substantial share of revenues to the market during the forecast period. The factors that are contributing to the growth are technological advancements, better healthcare infrastructure, a rise in demand for vascular access devices, and a rise in R&D investments for these devices in the regional market. 

KEY MARKET PARTICIPANTS

Companies playing a notable role in the Europe vascular access devices market profiled in this report are Becton Dickinson and Company, C.R. Bard Inc., Smiths Medical, Inc., Teleflex Incorporated, B Braun Melsungen Ag, AngioDynamics, Terumo Corporation, Nipro Medical Corporation, Edwards Lifesciences Corporation, Ameco Medical, Romsons Scientific & Surgical Pvt. Ltd, and Prodimed.

MARKET SEGMENTATION

This research report on the European vascular access devices market is segmented and sub-segmented into the following categories.

By Type

• Peripheral
• Central
• Accessories

By Application

• Drug Administration
• Fluid & Nutrition Administration
• Blood Transfusion
• Diagnostics Testing

By End Users

• Hospitals
• Clinics
• Ambulatory Care Centers
• Other End Users

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe